blue cross blue shield glp 1 coverage 2025 usa of Michigan won't cover popular weight-loss drugs Blue Cross Blue Shield of

Weight loss continued throughout the entire study period

GLP-1 therapy isnt only for weight loss

Recently, medications known as GLP-1 agonists, including Ozempic, have become increasingly popular due to their ability to support meaningful weight loss, even among individuals without diabetes

Precision is also paramount in terms of getting optimal treatment for people, and the appeal of different treatments might differ amongst people. GLP-1 Treatments Face Hurdles While GLP-1s offer promising benefits for some patients, significant barriers remain regarding supply, cost, and insurance coveragechallenges that Saunders describes as humongous limitations. Novo Nordisks Ozempic and Wegovy have been on the FDAs drug shortage list since 2022

But even as he calls for more robust data on long-term outcomes and safety in older adults, Batsis says that his skepticism regarding the benefits of these drugs has decreased over the past few years